Skip to main content

CAP TODAY/LightIntegra Technology Webinar: Platelet Activation Status and its Impact on Clinical Outcomes

Thank you

This live web event has ended. Thank you for attending.

Description

                  

Platelet Activation Status and
its Impact on Clinical Outcomes

Why should you register now for this webinar?
Hear national thought leaders discuss a new routine screening method for microparticles in platelet transfusions and the proper uses for activated vs. non-activated platelets
Brought to you by: CAP TODAY
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenters: Elisabeth Maurer, PhD, and Joel N. Kniep, MD

What will this webinar empower you to do?
Comprehend the current standard of care which assumes that all platelet transfusions are the same, when up to 50% of platelet inventory may be activated
Gain a thorough understanding of the advantages of giving the right platelets to the right patients and the challenge of not knowing platelet activation status
Realize that ThromboLUX removes platelet variation from the blood management process, reducing ineffective transfusions and refractory cases
Ask questions of our distinguished presenters

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from LightIntegra.

Contributors

  • Bob McGonnagle

    Publisher, CAP TODAY

  • Elisabeth Maurer, PhD

    Clinical Associate Professor
    University of British Columbia
    Founder & CTO, LightIntegra Technology Inc.

  • Joel N. Kniep, MD

    Assistant Medical Director, Transfusion Services, University of Colorado Hospital
    Assistant Professor, University of Colorado

May 23, 2019
Thu 1:30 PM EDT

Duration 1H 0M

This live web event has ended.

For Technical Support
+1 (858) 201-4136